Samsung Electronics Co., Ltd., and UC San Francisco (UCSF), one of the world’s premier health sciences universities, today announced a partnership to accelerate validation and commercialization of promising new sensors, algorithms, and digital health technologies for preventive health solutions.
North Shore-LIJ's Feinstein Institute for Medical Research announced today that it has received U.S. patent approval for a new device that could help physicians better monitor severe traumatic brain injuries, such as those suffered by combat.
In 2010, Ian Papautsky, associate professor in the University of Cincinnati's College of Engineering and Applied Science’s Department of Electrical Engineering and Computer Systems, formed a strategic partnership with renowned researchers from two other UC colleges—Erin Haynes, assistant professor in the College of Medicine’s Department of Environmental Health, and William Heineman, professor in the McMicken College of Arts and Sciences’ Department of Chemistry—to create a low-cost, portable sensor that could detect metal levels in a human blood sample. More specifically, he wanted to make a point-of-care sensor that would rapidly analyze (in real-time, 10 minutes or less) and detect dangerous amounts of manganese in children that could be administered by a person without a medical degree.
SporTracker Ltd., a leading provider of innovating Heart Rate Monitor (HRM) solutions for sport and leisure products, today announced the release of its new PPGv6 sensor for measurement of blood parameters, such as Heart Rate and Oxygen saturation.
At this week’s International Solid State Circuits Conference (ISSCC2014), imec and Holst Centre, together with Olympus, demonstrated a low-power single channel implantable electrocardiography (ECG) acquisition chip with analog feature extraction, which enables precise monitoring of the signal activity in a selected frequency band.
Research and Markets has announced the addition of the "Sensors for Home Healthcare Applications: Market & Technology Analysis" report to their offering.
Dexcom, Inc., the leader in continuous glucose monitoring (CGM), announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM device: Dexcom G4® PLATINUM (Pediatric) for use in children ages 2 to 17 years with diabetes. Already approved for adults 18 and older, the Dexcom G4 PLATINUM (Pediatric) is now the only CGM system approved for children as young as two years old.
BioControl Medical, a medical device company headquartered in Yehud, Israel, has received approval from the Israel Ministry of Health to conduct a clinical trial of its CardioFit® system in patients with chronic heart failure (HF) as part of INOVATE-HF.
Animas Canada, a division of LifeScan Canada Ltd., today announced the launch of the Animas® Vibe™ insulin pump and CGM system in Canada, providing a new diabetes management solution for Canadians living with Type 1 diabetes.
A recent study published in MEDSURG Nursing, the official Journal of the Academy of Medical-Surgical Nurses, reported: "Based on the results of this study, temporal artery thermometers appear to be a reliable way to measure temperature noninvasively in hospitalized patients."
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.